These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32415343)

  • 1. [Left atrial appendage closure for stroke prevention in atrial fibrillation : An update].
    Zimmermann F; Landmesser U
    Herz; 2020 Jun; 45(4):397-406. PubMed ID: 32415343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Catheter-based closure of the left atrial appendage : Stroke prevention in atrial fibrillation].
    Skurk C; Leistner DM; Park JW; Landmesser U
    Internist (Berl); 2016 Sep; 57(9):844-55. PubMed ID: 27534868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of percutaneous left atrial appendage closure in patients with atrial fibrillation: an update on patient outcomes.
    Kleinecke C; Gloekler S; Meier B
    Expert Rev Cardiovasc Ther; 2020 Aug; 18(8):517-530. PubMed ID: 32654527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left atrial appendage closure for stroke prevention.
    De Backer O; Loupis AM; Ihlemann N; Vejlstrup NG; Søndergaard L; Franzen OW
    Dan Med J; 2014 Aug; 61(8):A4879. PubMed ID: 25162439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
    Gangireddy SR; Halperin JL; Fuster V; Reddy VY
    Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?].
    Boersma LVA; Rensing BJWM; Wintgens LI; Klaver M; Swaans MJ
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
    Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
    Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
    Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.